SOAT1 and lichen planus: Tofacitinib, a JAK-STAT pathway inhibitor, shows promise in effectively treating these lesions.<h4>Abstract</h4>Lichen planus is a mucocutaneous disease that can cause various manifestations, such as itchy erythematous papules, cicatricial alopecia, erosion, and mucocutaneous ulcers.